Free Trial

SAB Biotherapeutics (SABS) Institutional Ownership

SAB Biotherapeutics logo
$3.68 -0.01 (-0.27%)
Closing price 04:00 PM Eastern
Extended Trading
$3.63 -0.05 (-1.44%)
As of 07:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for SAB Biotherapeutics (NASDAQ:SABS)

Current
Institutional Ownership
Percentage
7.82%
Number of
Institutional Buyers
(last 12 months)
26
Total
Institutional Inflows
(last 12 months)
$68.93M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$80.42K
Get SABS Insider Trade Alerts

Want to know when executives and insiders are buying or selling SAB Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

SABS Institutional Buying and Selling by Quarter

SAB Biotherapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/30/2026 Kestra Advisory Services LLC61,741$236K0.0%+434.6%0.121%
4/27/2026 Simplify Asset Management Inc.187,230$717K0.0%-10.1%0.367%
2/18/2026Perceptive Advisors LLC803,210$3.00M0.1%N/A1.687%
2/18/2026Millennium Management LLC324,090$1.21M0.0%N/A0.681%
2/18/2026Balyasny Asset Management L.P.475,439$1.78M0.0%N/A0.999%
2/17/2026ADAR1 Capital Management LLC26,344$99K0.0%+75.6%0.055%
2/17/2026ExodusPoint Capital Management LP86,113$322K0.0%N/A0.181%
2/17/2026Persistent Asset Partners Ltd19,790$74K0.0%N/A0.042%
2/16/2026OMERS ADMINISTRATION Corp42,000$157K0.0%N/A0.088%
2/16/2026Spruce Street Capital LP2,198,502$8.22M2.7%N/A4.618%
2/16/2026Verition Fund Management LLC26,867$100K0.0%N/A0.056%
2/16/2026Fifth Lane Capital LP15,000$56K0.0%N/A0.032%
2/13/2026Marshall Wace LLP236,460$884K0.0%N/A0.497%
2/13/2026State Street Corp13,122$49K0.0%N/A0.028%
2/11/2026Propel Bio Management LLC652,881$2.44M2.1%N/A1.371%
2/11/2026State of Wyoming8,971$34K0.0%N/A0.019%
2/10/2026Goldman Sachs Group Inc.51,348$192K0.0%+357.6%0.108%
2/9/2026Geode Capital Management LLC119,517$447K0.0%+39.4%0.251%
2/9/2026 Simplify Asset Management Inc.208,227$779K0.0%N/A0.437%
2/9/2026Jefferies Financial Group Inc.580,328$2.17M0.0%N/A1.219%
11/17/2025Woodline Partners LP2,850,881$5.73M0.0%N/A27.383%
11/17/2025Vivo Capital LLC11,420,000$22.95M1.8%N/A109.692%
11/17/2025RA Capital Management L.P.4,401,500$8.85M0.1%N/A42.277%
11/17/2025Commodore Capital LP4,401,500$8.85M0.4%N/A42.277%
11/14/2025Virtu Financial LLC19,982$40K0.0%N/A0.192%
11/14/2025ADAR1 Capital Management LLC15,000$30K0.0%N/A0.144%
11/12/2025Dimensional Fund Advisors LP15,781$32K0.0%N/A0.152%
10/23/2025 HB Wealth Management LLC307,500$618K0.0%N/A2.954%
5/7/2025HB Wealth Management LLC263,200$358K0.0%+10.9%2.833%
4/29/2025Silver Oak Securities Incorporated20,188$30K0.0%N/A0.217%
4/21/2025Silver Oak Securities Incorporated20,188$30K0.0%N/A0.217%
2/17/2025Millennium Management LLC29,411$112K0.0%-43.4%0.319%
2/14/2025Northern Trust Corp11,387$43K0.0%N/A0.123%
2/14/2025Diadema Partners LP30,000$114K0.0%N/A0.325%
2/12/2025Geode Capital Management LLC80,234$307K0.0%+18.8%0.869%
1/15/2025HB Wealth Management LLC237,400$982K0.0%+118.6%2.572%
11/15/2024Kovitz Investment Group Partners LLC19,201$52K0.0%N/A0.208%
11/15/2024RTW Investments LP635,276$1.72M0.0%-17.2%6.883%
7/17/2024First PREMIER Bank19,386$60K0.0%N/A0.210%
5/16/2024BVF Inc. IL917,826$4.17M0.1%-90.0%9.944%
2/15/2024BVF Inc. IL9,178,282$6.31M0.2%N/A175.426%
2/14/2024Commodore Capital LP1,831,746$1.26M0.1%N/A35.024%
2/14/2024RTW Investments LP9,178,282$6.31M0.1%N/A175.493%
11/8/2023Pathstone Family Office LLC506,513$319K0.0%N/A0.968%
8/9/2023Institutional & Family Asset Management LLC192,027$159K0.0%+28.2%0.381%
2/2/2023Silver Oak Securities Incorporated51,941$31K0.0%N/A0.121%
11/7/2022Institutional & Family Asset Management LLC149,774$105K0.0%+91.7%0.348%
10/20/2022First PREMIER Bank807,535$566K0.2%+23.8%1.877%
8/15/2022LGL Partners LLC23,000$33K0.0%N/A0.054%
8/3/2022AE Wealth Management LLC18,700$27K0.0%N/A0.044%
7/26/2022First PREMIER Bank652,440$946K0.3%N/A1.519%
5/9/2022Qube Research & Technologies Ltd24,179$91K0.0%+43.8%0.056%
2/14/2022Radcliffe Capital Management L.P.546,658$5.52M0.1%N/A1.257%
2/14/2022ETF Managers Group LLC13,202$105K0.0%N/A0.030%
2/14/2022Institutional & Family Asset Management LLC78,115$610K0.1%N/A0.180%
2/10/2022Qube Research & Technologies Ltd16,817$131K0.0%N/A0.039%
2/9/2022Wolverine Asset Management LLC6,602$51K0.0%N/A0.015%
2/9/2022Alps Advisors Inc.50,306$393K0.0%N/A0.116%


SABS Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of SABS shares?

During the previous two years, 33 institutional investors and hedge funds held shares of SAB Biotherapeutics. The most heavily invested institutionals were Vivo Capital LLC ($22.95M), Commodore Capital LP ($8.85M), RA Capital Management L.P. ($8.85M), Spruce Street Capital LP ($8.22M), Woodline Partners LP ($5.73M), BVF Inc. IL ($4.17M), and Perceptive Advisors LLC ($3.00M).Learn more on SAB Biotherapeutics' institutional investors.

What percentage of SAB Biotherapeutics' stock is owned by institutional investors?

7.82% of SAB Biotherapeutics' stock is owned by institutional investors. Learn more on SABS's institutional investor holdings.

Which institutional investors have been buying SAB Biotherapeutics' stock?

Of the 31 institutional investors that purchased SAB Biotherapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Vivo Capital LLC ($11.42M), RA Capital Management L.P. ($4.40M), Commodore Capital LP ($4.40M), Woodline Partners LP ($2.85M), Spruce Street Capital LP ($2.20M), Perceptive Advisors LLC ($803.21K), and Propel Bio Management LLC ($652.88K).

How much institutional buying is happening at SAB Biotherapeutics?

Institutional investors have bought a total of 29,284,405 shares in the last 24 months. This purchase volume represents approximately $68.93M in transactions.

Which of SAB Biotherapeutics' major shareholders have been selling company stock?

The following institutional investors have sold SAB Biotherapeutics stock in the last 24 months: Simplify Asset Management Inc. ($21.00K).

How much institutional selling is happening at SAB Biotherapeutics?

Institutional investors have sold a total of 20,997 shares in the last 24 months. This volume of shares sold represents approximately $80.42K in transactions.



This page (NASDAQ:SABS) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners